nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—adrenal gland cancer	0.716	1	CbGaD
Celecoxib—PDPK1—gonad—adrenal gland cancer	0.00385	0.0963	CbGeAlD
Celecoxib—PDPK1—pituitary gland—adrenal gland cancer	0.00376	0.0939	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—adrenal gland cancer	0.00354	1	CrCbGaD
Celecoxib—PDPK1—adrenal gland—adrenal gland cancer	0.00336	0.0839	CbGeAlD
Celecoxib—CYP2C9—urine—adrenal gland cancer	0.00309	0.0774	CbGeAlD
Celecoxib—CYP3A4—urine—adrenal gland cancer	0.00236	0.059	CbGeAlD
Celecoxib—CYP2D6—urine—adrenal gland cancer	0.00232	0.058	CbGeAlD
Celecoxib—MAPK14—pituitary gland—adrenal gland cancer	0.00201	0.0502	CbGeAlD
Celecoxib—CA14—cardiac atrium—adrenal gland cancer	0.002	0.05	CbGeAlD
Celecoxib—MAPK14—adrenal gland—adrenal gland cancer	0.0018	0.0449	CbGeAlD
Celecoxib—CA14—adrenal gland—adrenal gland cancer	0.00175	0.0437	CbGeAlD
Celecoxib—CA5B—gonad—adrenal gland cancer	0.0014	0.035	CbGeAlD
Celecoxib—CA5B—cardiac atrium—adrenal gland cancer	0.0014	0.035	CbGeAlD
Celecoxib—CA5B—adrenal gland—adrenal gland cancer	0.00122	0.0305	CbGeAlD
Celecoxib—CA2—adrenal cortex—adrenal gland cancer	0.000969	0.0242	CbGeAlD
Celecoxib—CA4—cardiac atrium—adrenal gland cancer	0.000967	0.0242	CbGeAlD
Celecoxib—ALB—adrenal gland—adrenal gland cancer	0.000948	0.0237	CbGeAlD
Celecoxib—CA4—pituitary gland—adrenal gland cancer	0.000944	0.0236	CbGeAlD
Celecoxib—ABCC4—adrenal gland—adrenal gland cancer	0.000918	0.0229	CbGeAlD
Celecoxib—CA4—adrenal gland—adrenal gland cancer	0.000843	0.0211	CbGeAlD
Celecoxib—CA2—cardiac atrium—adrenal gland cancer	0.000801	0.02	CbGeAlD
Celecoxib—CA2—pituitary gland—adrenal gland cancer	0.000783	0.0196	CbGeAlD
Celecoxib—PTGS2—adrenal cortex—adrenal gland cancer	0.000715	0.0179	CbGeAlD
Celecoxib—CA2—adrenal gland—adrenal gland cancer	0.000699	0.0175	CbGeAlD
Celecoxib—PTGS2—pituitary gland—adrenal gland cancer	0.000578	0.0144	CbGeAlD
Celecoxib—PTGS2—adrenal gland—adrenal gland cancer	0.000516	0.0129	CbGeAlD
Celecoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000169	0.000702	CbGpPWpGaD
Celecoxib—MAPK14—Cell-Cell communication—CTNNB1—adrenal gland cancer	0.000167	0.000692	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PRKACA—adrenal gland cancer	0.000165	0.000684	CbGpPWpGaD
Celecoxib—CA4—Metabolism—MED12—adrenal gland cancer	0.000164	0.000683	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PRKACA—adrenal gland cancer	0.000162	0.000674	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.00016	0.000665	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00016	0.000663	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000159	0.000662	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000159	0.000661	CbGpPWpGaD
Celecoxib—CA2—Metabolism—MED12—adrenal gland cancer	0.000158	0.000654	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	0.000156	0.000649	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000153	0.000637	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PRKACA—adrenal gland cancer	0.00015	0.000624	CbGpPWpGaD
Celecoxib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00015	0.000622	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—CDKN2A—adrenal gland cancer	0.000149	0.000621	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000149	0.000618	CbGpPWpGaD
Celecoxib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000149	0.000617	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—BAD—adrenal gland cancer	0.000148	0.000614	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000147	0.000611	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PRKACA—adrenal gland cancer	0.000145	0.000604	CbGpPWpGaD
Celecoxib—CA14—Metabolism—GNAS—adrenal gland cancer	0.000145	0.0006	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PRKACA—adrenal gland cancer	0.000144	0.000599	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000143	0.000592	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000142	0.00059	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—BAD—adrenal gland cancer	0.000142	0.00059	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ABCB1—adrenal gland cancer	0.000142	0.000589	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GNAS—adrenal gland cancer	0.000141	0.000585	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GNAS—adrenal gland cancer	0.000141	0.000585	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—CDC42—adrenal gland cancer	0.00014	0.00058	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ABCB1—adrenal gland cancer	0.000138	0.000574	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ABCB1—adrenal gland cancer	0.000138	0.000574	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000137	0.000568	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—EGFR—adrenal gland cancer	0.000135	0.000561	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000135	0.000561	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—BAD—adrenal gland cancer	0.000135	0.00056	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IGF2—adrenal gland cancer	0.000135	0.000559	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000134	0.000559	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PRKACA—adrenal gland cancer	0.000134	0.000558	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—GNAS—adrenal gland cancer	0.000133	0.000554	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MED12—adrenal gland cancer	0.000133	0.000552	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GNAS—adrenal gland cancer	0.000132	0.000546	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000131	0.000546	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	0.000131	0.000546	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TSHR—adrenal gland cancer	0.000131	0.000544	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PRKACA—adrenal gland cancer	0.00013	0.000539	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ABCB1—adrenal gland cancer	0.000129	0.000536	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000129	0.000536	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—RB1—adrenal gland cancer	0.000128	0.000534	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNRHR—adrenal gland cancer	0.000128	0.00053	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CDC42—adrenal gland cancer	0.000125	0.000518	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDC42—adrenal gland cancer	0.000123	0.000513	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MEN1—adrenal gland cancer	0.000123	0.000512	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—BRAF—adrenal gland cancer	0.000123	0.000509	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000123	0.000509	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000122	0.000508	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—CDC42—adrenal gland cancer	0.000122	0.000508	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GNAS—adrenal gland cancer	0.000122	0.000506	CbGpPWpGaD
Celecoxib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000121	0.000502	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PRKACA—adrenal gland cancer	0.00012	0.000498	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ABCB1—adrenal gland cancer	0.00012	0.000497	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—adrenal gland cancer	0.000119	0.000494	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000119	0.000494	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000119	0.000493	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000118	0.000491	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IGF2—adrenal gland cancer	0.000118	0.00049	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—GNAS—adrenal gland cancer	0.000117	0.000485	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000116	0.00048	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PRKACA—adrenal gland cancer	0.000115	0.000477	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000115	0.000477	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CDC42—adrenal gland cancer	0.000114	0.000473	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000113	0.000471	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.000113	0.000469	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000111	0.000463	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000111	0.00046	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CDC42—adrenal gland cancer	0.00011	0.000457	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—adrenal gland cancer	0.000109	0.000455	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SH3KBP1—adrenal gland cancer	0.000108	0.000449	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000107	0.000446	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SDHB—adrenal gland cancer	0.000107	0.000443	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—adrenal gland cancer	0.000104	0.000433	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MED12—adrenal gland cancer	0.000103	0.000428	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ZNRF3—adrenal gland cancer	0.000102	0.000422	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MEN1—adrenal gland cancer	9.85e-05	0.000409	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—adrenal gland cancer	9.85e-05	0.000409	CbGpPWpGaD
Celecoxib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.8e-05	0.000407	CbGpPWpGaD
Celecoxib—CA14—Metabolism—POMC—adrenal gland cancer	9.73e-05	0.000404	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTNNB1—adrenal gland cancer	9.73e-05	0.000404	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GNAS—adrenal gland cancer	9.72e-05	0.000404	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	9.7e-05	0.000403	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PRKACA—adrenal gland cancer	9.69e-05	0.000402	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—POMC—adrenal gland cancer	9.57e-05	0.000397	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ABCB1—adrenal gland cancer	9.53e-05	0.000396	CbGpPWpGaD
Celecoxib—CA6—Metabolism—POMC—adrenal gland cancer	9.49e-05	0.000394	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—POMC—adrenal gland cancer	9.49e-05	0.000394	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PRKACA—adrenal gland cancer	9.41e-05	0.000391	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GNAS—adrenal gland cancer	9.32e-05	0.000387	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.3e-05	0.000386	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ABCB1—adrenal gland cancer	9.14e-05	0.00038	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TERT—adrenal gland cancer	9.14e-05	0.00038	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	9.13e-05	0.000379	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	9.11e-05	0.000378	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—adrenal gland cancer	9.02e-05	0.000375	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—POMC—adrenal gland cancer	8.86e-05	0.000368	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SPARC—adrenal gland cancer	8.83e-05	0.000367	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—POMC—adrenal gland cancer	8.69e-05	0.000361	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SDHB—adrenal gland cancer	8.62e-05	0.000358	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—BAD—adrenal gland cancer	8.61e-05	0.000358	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	8.38e-05	0.000348	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—adrenal gland cancer	8.32e-05	0.000345	CbGpPWpGaD
Celecoxib—CA12—Metabolism—POMC—adrenal gland cancer	8.2e-05	0.000341	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	8.14e-05	0.000338	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDC42—adrenal gland cancer	7.98e-05	0.000331	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	7.96e-05	0.000331	CbGpPWpGaD
Celecoxib—PDPK1—Disease—BAD—adrenal gland cancer	7.95e-05	0.00033	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	7.89e-05	0.000328	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GNAS—adrenal gland cancer	7.85e-05	0.000326	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.82e-05	0.000325	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—adrenal gland cancer	7.76e-05	0.000322	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—adrenal gland cancer	7.71e-05	0.00032	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ABCB1—adrenal gland cancer	7.7e-05	0.00032	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF2—adrenal gland cancer	7.69e-05	0.000319	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—BAD—adrenal gland cancer	7.68e-05	0.000319	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	7.65e-05	0.000318	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNRH1—adrenal gland cancer	7.64e-05	0.000317	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GNAS—adrenal gland cancer	7.62e-05	0.000317	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.61e-05	0.000316	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—adrenal gland cancer	7.57e-05	0.000314	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—adrenal gland cancer	7.57e-05	0.000314	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PRKACA—adrenal gland cancer	7.56e-05	0.000314	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PRKACA—adrenal gland cancer	7.45e-05	0.00031	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1R—adrenal gland cancer	7.43e-05	0.000309	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—adrenal gland cancer	7.4e-05	0.000307	CbGpPWpGaD
Celecoxib—PDPK1—Disease—BRAF—adrenal gland cancer	7.24e-05	0.000301	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—adrenal gland cancer	7.19e-05	0.000299	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SDHB—adrenal gland cancer	7.12e-05	0.000296	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—adrenal gland cancer	7.06e-05	0.000293	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SDHB—adrenal gland cancer	7.06e-05	0.000293	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—adrenal gland cancer	7.02e-05	0.000292	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPRY2—adrenal gland cancer	6.99e-05	0.00029	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SDHD—adrenal gland cancer	6.87e-05	0.000285	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—RRM1—adrenal gland cancer	6.87e-05	0.000285	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TSHR—adrenal gland cancer	6.81e-05	0.000283	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.78e-05	0.000282	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—adrenal gland cancer	6.54e-05	0.000272	CbGpPWpGaD
Celecoxib—CA4—Metabolism—POMC—adrenal gland cancer	6.54e-05	0.000272	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.45e-05	0.000268	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDC42—adrenal gland cancer	6.41e-05	0.000266	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MEN1—adrenal gland cancer	6.4e-05	0.000266	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TERT—adrenal gland cancer	6.4e-05	0.000266	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SPRY2—adrenal gland cancer	6.38e-05	0.000265	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CDC42—adrenal gland cancer	6.32e-05	0.000263	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—adrenal gland cancer	6.29e-05	0.000261	CbGpPWpGaD
Celecoxib—CA2—Metabolism—POMC—adrenal gland cancer	6.27e-05	0.000261	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	6.2e-05	0.000257	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF2—adrenal gland cancer	6.09e-05	0.000253	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—GNAS—adrenal gland cancer	6.04e-05	0.000251	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—adrenal gland cancer	5.85e-05	0.000243	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MEN1—adrenal gland cancer	5.84e-05	0.000243	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CTNNB1—adrenal gland cancer	5.72e-05	0.000238	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTNNB1—adrenal gland cancer	5.67e-05	0.000235	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—BAD—adrenal gland cancer	5.57e-05	0.000231	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SDHD—adrenal gland cancer	5.55e-05	0.000231	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RRM1—adrenal gland cancer	5.55e-05	0.000231	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.55e-05	0.000231	CbGpPWpGaD
Celecoxib—CA9—Metabolism—POMC—adrenal gland cancer	5.29e-05	0.00022	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CTNNB1—adrenal gland cancer	5.23e-05	0.000217	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.23e-05	0.000217	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—adrenal gland cancer	5.22e-05	0.000217	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	5.2e-05	0.000216	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	5.2e-05	0.000216	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—POMC—adrenal gland cancer	5.13e-05	0.000213	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.13e-05	0.000213	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MED12—adrenal gland cancer	5.12e-05	0.000213	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—BRAF—adrenal gland cancer	5.07e-05	0.000211	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTNNB1—adrenal gland cancer	5.05e-05	0.00021	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—adrenal gland cancer	5e-05	0.000208	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—adrenal gland cancer	4.91e-05	0.000204	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKACA—adrenal gland cancer	4.89e-05	0.000203	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	4.65e-05	0.000193	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RRM1—adrenal gland cancer	4.59e-05	0.00019	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SDHD—adrenal gland cancer	4.59e-05	0.00019	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.58e-05	0.00019	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SDHD—adrenal gland cancer	4.55e-05	0.000189	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RRM1—adrenal gland cancer	4.55e-05	0.000189	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—adrenal gland cancer	4.53e-05	0.000188	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—adrenal gland cancer	4.49e-05	0.000186	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BAD—adrenal gland cancer	4.47e-05	0.000186	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRKACA—adrenal gland cancer	4.46e-05	0.000185	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—adrenal gland cancer	4.27e-05	0.000177	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—adrenal gland cancer	4.22e-05	0.000175	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDC42—adrenal gland cancer	4.15e-05	0.000172	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—adrenal gland cancer	4.14e-05	0.000172	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MED12—adrenal gland cancer	4.14e-05	0.000172	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—adrenal gland cancer	4e-05	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF2—adrenal gland cancer	4e-05	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNAS—adrenal gland cancer	3.96e-05	0.000165	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1R—adrenal gland cancer	3.86e-05	0.00016	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDC42—adrenal gland cancer	3.78e-05	0.000157	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—adrenal gland cancer	3.73e-05	0.000155	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PRKACA—adrenal gland cancer	3.73e-05	0.000155	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.7e-05	0.000154	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.66e-05	0.000152	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.42e-05	0.000142	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MED12—adrenal gland cancer	3.39e-05	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TERT—adrenal gland cancer	3.33e-05	0.000138	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TERT—adrenal gland cancer	3.03e-05	0.000126	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.03e-05	0.000126	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNAS—adrenal gland cancer	3.03e-05	0.000126	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PRKACA—adrenal gland cancer	3.02e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3e-05	0.000125	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCB1—adrenal gland cancer	2.97e-05	0.000123	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.95e-05	0.000123	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTNNB1—adrenal gland cancer	2.94e-05	0.000122	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—adrenal gland cancer	2.9e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BAD—adrenal gland cancer	2.89e-05	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—adrenal gland cancer	2.67e-05	0.000111	CbGpPWpGaD
Celecoxib—PTGS2—Disease—BAD—adrenal gland cancer	2.64e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BRAF—adrenal gland cancer	2.63e-05	0.000109	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.49e-05	0.000104	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.47e-05	0.000103	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNAS—adrenal gland cancer	2.45e-05	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—adrenal gland cancer	2.44e-05	0.000101	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.42e-05	0.0001	CbGpPWpGaD
Celecoxib—PTGS2—Disease—BRAF—adrenal gland cancer	2.4e-05	9.98e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCB1—adrenal gland cancer	2.4e-05	9.98e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—adrenal gland cancer	2.33e-05	9.69e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.24e-05	9.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—adrenal gland cancer	2.04e-05	8.46e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.02e-05	8.4e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2e-05	8.32e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.98e-05	8.24e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.97e-05	8.17e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—adrenal gland cancer	1.93e-05	8.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CTNNB1—adrenal gland cancer	1.9e-05	7.91e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CTNNB1—adrenal gland cancer	1.74e-05	7.21e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—adrenal gland cancer	1.65e-05	6.85e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.63e-05	6.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—adrenal gland cancer	1.51e-05	6.26e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—adrenal gland cancer	1.38e-05	5.71e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.36e-05	5.65e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.35e-05	5.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.32e-05	5.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—adrenal gland cancer	1.31e-05	5.46e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.3e-05	5.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—adrenal gland cancer	1.27e-05	5.26e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.09e-05	4.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.08e-05	4.47e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—adrenal gland cancer	8.9e-06	3.7e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.1e-06	2.95e-05	CbGpPWpGaD
